International Society of Thrombosis and Haemostasis (ISTH) interim guidance on recognition and management of coagulopathy in COVID‐19

Based on this study and the experience from published literature on septic coagulopathy, monitoring PT, Ddimer, platelet count and fibrinogen can be helpful in determining prognosis in COVID-19 patients requiring hospital admission. 8, 9,10 If there is worsening of these parameters, more aggressive critical care support is warranted and consideration should be given for more ‘experimental’ therapies in and blood product support as appropriate. If these makers are stable or improving, it gives the added confidence for stepdown of treatment if corroborating with the clinical condition.


Leave a Reply

Your email address will not be published. Required fields are marked *